COMMUNIQUÉS West-GlobeNewswire

-
Surface Oncology Resets Portfolio Priorities, Extends Cash Runway Through 2021
18/12/2018 -
AlterG® Files Lawsuit Against Boost, Inc. for Patent Infringement, Misappropriation of Trade Secrets, and False Advertising
18/12/2018 -
Movember Campaign Unmasks Men’s Health Issues
18/12/2018 -
Creso Pharma Brings Together Cannabis Experts Across Several Verticals-- CFN Media
18/12/2018 -
Conformis Announces Common Stock Purchase Agreement with Institutional Investor, Lincoln Park Capital Fund
18/12/2018 -
Canopy Rivers Portfolio Company TerrAscend Gains Traction in New Jersey Medical Cannabis Market
18/12/2018 -
RavenQuest Announces Significant Supply Agreement With Wayland Group
18/12/2018 -
BLVD Centers Announces Date and Time for Conference Call
18/12/2018 -
Information concerning the total number of voting rights and shares
18/12/2018 -
Informations relatives au nombre total de droits de vote et d'actions
18/12/2018 -
Catalyst Biosciences Hosts Research & Development Day Focused on Factor VIIa and Factor IX Hemophilia Programs
18/12/2018 -
Catalyst Pharmaceuticals Announces Definitive Agreement with Endo for Vigabatrin Tablets
18/12/2018 -
Hernia Surgeon Discusses Surgery Costs in Los Angeles
18/12/2018 -
ProQR annonce la publication dans Nature Medicine des données du QR-110 pour l’amaurose congénitale de Leber 10
18/12/2018 -
Communique from EGM in Oncology Venture A/S
18/12/2018 -
Wildflower to Capitalize on Hemp Legalization
18/12/2018 -
NanoVibronix Signs with Exclusive Distributor in Switzerland for UroShield®
18/12/2018 -
Golden Leaf Holdings Ltd. Not Pursuing Terra Tech Corp. Transaction
18/12/2018 -
Easton Pharmaceuticals Completes Purchase of Development Project with Total Projected Profit in Excess of $30 Million
18/12/2018
Pages